Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (UM1-AI068619, UM1-AI068617 and UM1-AI068613)
Received: 22 July 2020
Accepted: 29 December 2020
First Online: 12 January 2021
Ethics approval and consent to participate
: The University of Zambia Biomedical Research Ethics Committee (UNZABREC) and Ministry of Health, Zambia, approved the trial in July 2016. The trial was also approved by the London School of Hygiene and Tropical Medicine (LSHTM). Written informed consent was obtained from all participants prior to enrolment into the trial. Zambart and LSHTM affiliated investigators will have full access to all datasets collected from this study. HPTN investigators will only have access to de-identified versions of the datasets.
: Not applicable
: The authors declare they have no competing interests.